|4Jul 16, 1:25 PM ET

Sung Elsa 4

4 · Jiangbo Pharmaceuticals, Inc. · Filed Jul 16, 2010

Insider Transaction Report

Form 4
Period: 2010-04-21
Sung Elsa
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.001

    2010-04-21+9141,414 total
  • Award

    Option

    2008-06-10+2,0002,000 total
    Exercise: $12.00From: 2008-07-01Exp: 2013-06-10Common Stock (2,000 underlying)
  • Award

    Option

    2008-06-10+1,7503,750 total
    Exercise: $16.00From: 2008-12-31Exp: 2013-06-10Common Stock (1,750 underlying)
  • Award

    Option

    2008-06-10+1,8757,500 total
    Exercise: $24.00From: 2009-12-31Exp: 2013-06-10Common Stock (1,875 underlying)
  • Award

    Option

    2008-06-10+1,8755,625 total
    Exercise: $20.00From: 2009-06-30Exp: 2013-06-10Common Stock (1,875 underlying)
Footnotes (2)
  • [F1]No purchase price paid. Shares were issued to the reporting person by the Issuer for services rendered as the Chief Financial Officer of the Issuer.
  • [F2]Options were issued as part of compensation to the reporting person.

Documents

1 file
  • 4
    v190771_ex.xmlPrimary